Literature DB >> 18559949

Genes contributing to prion pathogenesis.

Gültekin Tamgüney1,2, Kurt Giles1,2, David V Glidden3, Pierre Lessard2, Holger Wille1,2, Patrick Tremblay1,2, Darlene F Groth2, Fruma Yehiely2, Carsten Korth2, Richard C Moore2, Jörg Tatzelt1, Eric Rubinstein4, Claude Boucheix4, Xiaoping Yang5, Pamela Stanley5, Michael P Lisanti6, Raymond A Dwek7, Pauline M Rudd7, Jackob Moskovitz8, Charles J Epstein9, Tracey Dawson Cruz10, William A Kuziel10, Nobuyo Maeda10, Jan Sap11, Karen Hsiao Ashe12, George A Carlson13, Ina Tesseur14, Tony Wyss-Coray15,14, Lennart Mucke16,17,1, Karl H Weisgraber18,16, Robert W Mahley18,16, Fred E Cohen19,2, Stanley B Prusiner1,2.   

Abstract

Prion diseases are caused by conversion of a normally folded, non-pathogenic isoform of the prion protein (PrP(C)) to a misfolded, pathogenic isoform (PrP(Sc)). Prion inoculation experiments in mice expressing homologous PrP(C) molecules on different genetic backgrounds displayed different incubation times, indicating that the conversion reaction may be influenced by other gene products. To identify genes that contribute to prion pathogenesis, we analysed incubation times of prions in mice in which the gene product was inactivated, knocked out or overexpressed. We tested 20 candidate genes, because their products either colocalize with PrP, are associated with Alzheimer's disease, are elevated during prion disease, or function in PrP-mediated signalling, PrP glycosylation, or protein maintenance. Whereas some of the candidates tested may have a role in the normal function of PrP(C), our data show that many genes previously implicated in prion replication have no discernible effect on the pathogenesis of prion disease. While most genes tested did not significantly affect survival times, ablation of the amyloid beta (A4) precursor protein (App) or interleukin-1 receptor, type I (Il1r1), and transgenic overexpression of human superoxide dismutase 1 (SOD1) prolonged incubation times by 13, 16 and 19 %, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559949      PMCID: PMC2828448          DOI: 10.1099/vir.0.2008/001255-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  68 in total

1.  Severely reduced female fertility in CD9-deficient mice.

Authors:  F Le Naour; E Rubinstein; C Jasmin; M Prenant; C Boucheix
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

2.  Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice.

Authors:  C S von Koch; H Zheng; H Chen; M Trumbauer; G Thinakaran; L H van der Ploeg; D L Price; S S Sisodia
Journal:  Neurobiol Aging       Date:  1997 Nov-Dec       Impact factor: 4.673

3.  Regulation by neurotransmitter receptors of serotonergic or catecholaminergic neuronal cell differentiation.

Authors:  S Mouillet-Richard; V Mutel; S Loric; C Tournois; J M Launay; O Kellermann
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

4.  Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene.

Authors:  N Kojima; J Wang; I M Mansuy; S G Grant; M Mayford; E R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Expression of type I interleukin-1 receptor mRNA and its regulation in cultured astrocytes.

Authors:  Y Tomozawa; T Inoue; M Satoh
Journal:  Neurosci Lett       Date:  1995-07-28       Impact factor: 3.046

6.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females.

Authors:  J Raber; D Wong; M Buttini; M Orth; S Bellosta; R E Pitas; R W Mahley; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Role of interleukin-1 in prion disease-associated astrocyte activation.

Authors:  Julia Schultz; Anja Schwarz; Sabine Neidhold; Michael Burwinkel; Constanze Riemer; Dietrich Simon; Manfred Kopf; Markus Otto; Michael Baier
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

8.  Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie.

Authors:  I L Campbell; M Eddleston; P Kemper; M B Oldstone; M V Hobbs
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies.

Authors:  S B Prusiner; D Groth; A Serban; R Koehler; D Foster; M Torchia; D Burton; S L Yang; S J DeArmond
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  63 in total

Review 1.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

Review 2.  Prions.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 3.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

4.  Polymorphisms in the HSP90AA1 5' flanking region are associated with scrapie incubation period in sheep.

Authors:  Ane Marcos-Carcavilla; Carole Moreno; Magdalena Serrano; Pascal Laurent; Edmond P Cribiu; Olivier Andréoletti; Julien Ruesche; Jean-Louis Weisbecker; Jorge H Calvo; Katayoun Moazami-Goudarzi
Journal:  Cell Stress Chaperones       Date:  2009-10-18       Impact factor: 3.667

5.  Drug resistance confounding prion therapeutics.

Authors:  David B Berry; Duo Lu; Michal Geva; Joel C Watts; Sumita Bhardwaj; Abby Oehler; Adam R Renslo; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-15       Impact factor: 11.205

6.  Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Hidefumi Furuoka; Motohiro Horiuchi
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 7.  Therapies for human prion diseases.

Authors:  Peter K Panegyres; Elizabeth Armari
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

8.  Engineering a murine cell line for the stable propagation of hamster prions.

Authors:  Matthew E C Bourkas; Hamza Arshad; Zaid A M Al-Azzawi; Ondrej Halgas; Ronald A Shikiya; Mohadeseh Mehrabian; Gerold Schmitt-Ulms; Jason C Bartz; Joel C Watts
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

9.  Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP.

Authors:  Tamar Canello; Kati Frid; Ronen Gabizon; Silvia Lisa; Assaf Friedler; Jackob Moskovitz; María Gasset; Ruth Gabizon
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  Measuring prions by bioluminescence imaging.

Authors:  Gültekin Tamgüney; Kevin P Francis; Kurt Giles; Azucena Lemus; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.